Healthcare -
Biotechnology - NASDAQ - NL
$ 39.45
-0.504 %
$ 2.7 B
Market Cap
-9.72
P/E
Price Target
Average
105.91%
Revenue Forecast
Estimate
114.44%
EBIT
Estimate
--40.41%
Net Income
Estimate
11.35%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Merus N.V.
Wall Street analysts predict an average 1-year price target for MRUS of $81.2 , with forecasts ranging from
a
low of
$58 to a high of $99 .
MRUS Lowest Price Target
Wall Street Target
58 USD
47.02%
MRUS Average Price Target
Wall Street Target
81.2 USD
105.91%
MRUS Highest Price Target
Wall Street Target
99 USD
150.95%
REVENUE FORECAST
Revenue Forecast Chart MRUS
EBIT FORECAST
EBIT Forecast Chart MRUS
NET INCOME FORECAST
Net Income Chart MRUS